Recently, there is a growing interest in the clinical evaluation of PSMA-PET imaging in detecting ccRCC and its metastases [15–17] since PSMA-PET imaging showed superior performance in the staging or diagnostic of recurrence in patient with RCC. Here, FOLH1 is linked to nonpapillary renal cell carcinoma.